🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
To evaluate the efficacy and safety of two concentrations of PRT-2761 as a ...
Status
Completed
Location
Andover Eye Associates
Start Date
2017-10-13
Trial ID
NCT03320434
Treatments Being Tested
A study to demonstrate the superiority of test article nasal spray relative...
Status
Completed
Location
Kenilworth/IL
Start Date
2007-09
Trial ID
NCT00578929
Treatments Being Tested
The purpose of this study was to evaluate the ocular safety of an investiga...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01698814
Treatments Being Tested
The purpose of the study is to assess the safety of the study drug, Patanas...
Status
Completed
Location
Niran Amar, M.D.
Start Date
2008-10
Trial ID
NCT00794144
Treatments Being Tested
This study is to assess the Onset of Action and Efficacy of azelastine hydr...
Status
Completed
Location
Cliantha Research
Start Date
2023-10-30
Trial ID
NCT06126952
The purpose of this study was to assess local nasal adverse effects, as wel...
Status
Completed
Location
Contact Alcon Call Center For Trial Locations
Start Date
2008-11
Trial ID
NCT00789555
The purpose of this study was to assess the safety and efficacy of AL-4943A...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01479374
The purpose of this study is to demonstrate that Olopatadine 0.2% is superi...
Status
Completed
Location
Multiple Locations
Start Date
2006-04-18
Trial ID
NCT00331500
The purpose of the study is to demonstrate safety and efficacy of Olopatadi...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00987272